Dermavant Sciences, an Organon company
Dermavant Sciences, an Organon company

Dermavant Sciences, an Organon company Information

Contact top employees from Dermavant Sciences, an Organon compan...

Summary

Dermavant Sciences, an Organon company is a private company that has been in the industry for 11 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Todd Zavodnick. Its headquarters is located at Long Beach, California, USA. The number of employees ranges from 100 to 250. The annual revenue of Dermavant Sciences, an Organon company varies between 5.0M and 25M. Total funding of the company - $40M. To connect with Dermavant Sciences, an Organon company employee register on SignalHire.

Organization Website

dermavant.com

Social Links

linkedIn

Phone Number

919-767-3277

Industries

Headquarters Location

3780 Kilroy Airport Way, Long Beach, CA, 90806 US

Employees Size

200-500 employees

Specialties

Medical Dermatology

SIC Code

2836

DMA Code

Los Angeles Metropolitan Area

Founded

2016

Estimated Annual Revenue

$5.0M - 25M

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2012Public
Company
25 - 100 5.2M $409.9M
2009Public
Company
1 - 25 < 1M $33.5M
2015Privately
Held
1 - 25 3M $4.7M
2017Public
Company
1 - 25 < 1M $855.3K

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Dermavant Sciences, an Organon company shows a diverse range of experience levels:
9% have been with the company for less than 1 year39% for 1–2 years25% for 3–4 years16% for 5–7 years7% for 8–10 years5% have over 11 years of service at Dermavant Sciences, an Organon company
Ex-employees positions
In Company
In New Company
Contact top employees from Dermavant Sciences, an Organon compan...
Diane Javier
Strategic Relations Director- West
View
Timothy Wilson
Director Biostatistics
View
Robert Singleton
Senior Manager, Field Training
View
Brad Greenfield
District Business Manager
View
Kyle Sheehan
Territory Business Manager
View
Lauren Robertson
Territory Business Manager
View
Randy Read
Sales Training Team Member
View
Chelsea Steed Murphy
Territory Business Manager
View
Erica Hennig Reid
Strategic Account Manager
View
Jaclyn Skeber
Territory Business Manager
View
Brianna Klose
Territory Business Manager
View
Catie Owaroff
Territory Business Manager
View
Christopher Zoghby
Territory Business Manager
View
Samir Pathan
Field Sales Trainer
View
Bill Matz
Territory Business Manager
View
Shannon Schmaltz
Territory Business Manager
View
Sheila Zezza
Territory Business Manager
View
Troy Abbott
District Business Manager
View
Jason Kerns
Director, CMC / Tech Ops
View
Amanda Knighten
Territory Business Manager
View
Lauren Gallagher
Territory Business Manager
View
Hillary Shemler
Territory Business Manager
View
Marisa Salinas
Regional Scientific Director
View
Madison Ehin
Field Skills Trainer
View
Kelly Arentsen
Account Manager
View
Debra Thorn
Director, Regulatory Affairs Advertising/Promotions
View
Katherine Lacroix
Non Executive Director
View
Vincent Calasso
Territory Business Manager
View
Christopher McCaulsky
Territory Business Manager
View

FAQ

Dermavant Sciences, an Organon company operates in the Biotech industries. More details can be found on the official website: dermavant.com.
The headquarters of Dermavant Sciences, an Organon company are located in Long Beach, United States.
The current CEO of Dermavant Sciences, an Organon company is Todd Zavodnick
You can contact Dermavant Sciences, an Organon company by phone at 919-767-3277.
Dermavant Sciences, an Organon company currently employs 200-500 people.
Dermavant Sciences, an Organon company's revenue is approximately 13.4M.
Well-known competitors of Dermavant Sciences, an Organon company include Aclaris Therapeutics, Inc., Brickell Biotech, Inc., MatriSys Bioscience, Inc. and CNS Pharmaceuticals, Inc..
BACK TO TOP